A comparison of serum anti-mullerian hormone and cycle baseline follicle stimulating hormone in prediction of IVF outcomes

被引：0
|
作者：
Singer, T.
Barad, D.
Gleicher, N.
机构：
[1] Ctr Human Reprod, New York, NY USA
[2] Lenox Hill Hosp, Dept Obstet & Gynecol, New York, NY 10021 USA
来源：
FERTILITY AND STERILITY | 2007年 / 88卷
关键词：
D O I：
10.1016/j.fertnstert.2007.07.318
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [1] COMPARATIVE ANALYSIS OF SERUM ANTI-MULLERIAN HORMONE, SERUM FOLLICLE STIMULATING HORMONE AND SERUM ESTRADIOL IN THE PREDICTION OF OVARIAN RESERVE
    Meherishi, Shuchita
    Garg, Swati
    Agarwal, Neha
    Jindal, Manvi
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2013, 2 (18): : 3097 - 3103
  • [2] Serum Anti-mullerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles
    Sahmay, Sezai
    Demirayak, Gokhan
    Guralp, Onur
    Ocal, Pelin
    Senturk, Levent M.
    Oral, Engin
    Irez, Tulay
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2012, 29 (07) : 589 - 595
  • [3] Assessment of ovarian reserve with anti-Mullerian hormone: a comparison of the predictive value of anti-Mullerian hormone, follicle-stimulating hormone, inhibin B, and age
    Riggs, Ryan M.
    Duran, E. Hakan
    Baker, Margaret W.
    Kimble, Thomas D.
    Hobeika, Elie
    Yin, Larry
    Matos-Bodden, Lira
    Leader, Ben
    Stadtmauer, Laurel
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (02) : 202.e1 - 202.e8
  • [4] Low circulating anti-Mullerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?
    Grzegorczyk, V.
    Khrouf, M.
    Bringer, S.
    Mayenga, J. M.
    Kulski, O.
    Cohen-Bacrie, P.
    Benaim, J. L.
    HUMAN REPRODUCTION, 2010, 25 : I88 - I88
  • [5] Low circulating anti-Mullerian hormone and normal follicle stimulating hormone levels: Which prognosis in an IVF program?
    Grzegorczyk-Martin, V.
    Khrouf, M.
    Bringer-Deutsch, S.
    Mayenga, J. -M.
    Kuski, O.
    Cohen-Bacrie, P.
    Benaim, J. -L.
    Belaisch-Allart, J.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2012, 40 (7-8): : 411 - 418
  • [6] Comparison of serum concentration of anti-mullerian hormone and follicle stimulating hormone with length of telomeres in women with premature ovarian insufficiency
    Pogacnik, Renata Kosir
    Slabe, Nina
    Novakovic, Srdjan
    Cerkovnik, Petra
    Vrtovec, Helena Meden
    Kodre, Anamarija Rebolj
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 109 - 109
  • [7] MATERNAL SERUM CONCENTRATIONS OF FOLLICLE STIMULATING HORMONE AND ANTI-MULLERIAN HORMONE AS PREDICTORS OF SUCCESSFUL BLASTOCYST DEVELOPMENT DURING IVF TREATMENT.
    Sadruddin, S.
    Barnett, B. D.
    Ku, L. T.
    Havemann, D. L.
    Mucowski, S. J.
    Herrington, R. S.
    Burggren, W. W.
    FERTILITY AND STERILITY, 2018, 110 (04) : E358 - E358
  • [8] Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone
    Jamil, Zehra
    Fatima, Syeda Sadia
    Cheema, Zahra
    Baig, Safia
    Choudhary, Roha Ahmed
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2016, 21
  • [9] ANTI-MULLERIAN HORMONE (AMH), ANTRAL FOLLICLE COUNT (AFC) AND AGE PREDICT IVF OUTCOMES SIGNIFICANTLY BETTER THAN FOLLICLE STIMULATING HORMONE (FSH).
    Gada, R.
    Morbeck, D.
    Amols, M.
    Rollene, N.
    Jensen, J.
    Coddington, C.
    FERTILITY AND STERILITY, 2010, 94 (04) : S97 - S97
  • [10] Correlation of serum anti-Mullerian hormone to follicular follicle stimulating hormone and implantation potential of the ensuing embryos
    Lee, Maw-Sheng
    Tzeng, Shu-Ling
    Yang, Shun-Fa
    Lin, Yi-Ping
    Cheng, En-Hui
    Huang, Chun-Chia
    Yang, Yu-Shih
    Lee, Tsung-Hsien
    CLINICA CHIMICA ACTA, 2017, 471 : 327 - 333
12345